Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

What other immunotherapy options are there in recurrent metastatic disease?

Current overview and how to select patients in first-line

Date

17 Oct 2020

Session

What other immunotherapy options are there in recurrent metastatic disease?

Topics

Immunotherapy

Tumour Site

Presenters

Jean-Pascal Machiels

Authors

J. Machiels

Author affiliations

Department Of Oncology, Cliniques Universitaires Saint-Luc (UCLouvain Saint-Luc), 1200 - Woluwe-Saint-Lambert/BE

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

17 Oct 2020

Beyond the use of checkpoint inhibitor

Presenter: Ezra Cohen

Session: What other immunotherapy options are there in recurrent metastatic disease?

Resources:

Slides

Webcast

17 Oct 2020

Immunotherapy in NPC

Presenter: Brigette Ma

Session: What other immunotherapy options are there in recurrent metastatic disease?

Resources:

Slides

Webcast

17 Oct 2020

Q&A and live discussion

Presenter: Ana Martins Ferreira Castro

Session: What other immunotherapy options are there in recurrent metastatic disease?

Resources:

Webcast